Suchergebnisse - "Moretto, Roberto"

PubPharm (74)

11

Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses

enthalten in: PloS one | 2023

von D'Angelo, A. | Kilili, H. | Chapman, R. | +18

12

Impact of baseline gadoxetic acid-enhanced liver magnetic resonance and diffusion-weighted imaging in resectable colorectal liver metastases : A prospective, monocentric study

enthalten in: Surgical oncology | 2022

von Moretto, R. | Borelli, B. | Boraschi, P. | +13

13

Benefit from upfront FOLFOXIRI and bevacizumab in BRAFV600E-mutated metastatic colorectal cancer patients : does primary tumour location matter?

enthalten in: British journal of cancer | 2022

von Moretto, R. | Elliott, A. | Rossini, D. | +21

14

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer : The Phase III TRIPLETE Study by GONO

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Rossini, D. | Antoniotti, C. | Lonardi, S. | +25

15

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE) : a multicentre, open-label, randomised, controlled, phase 2 trial

enthalten in: The Lancet. Oncology | 2022

von Antoniotti, C. | Rossini, D. | Pietrantonio, F. | +35

CommentIn: Lancet Oncol. 2022 Jul;23(7):830-831. - PMID 35636443

16

Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer : an Open-Label, Multicenter, Phase Ib Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Hubbard, J. | Tőke, E. | Moretto, R. | +9

17

Upper transversal hepatectomy with double hepatic vein resection and reconstruction to treat colorectal cancer liver metastases at the hepatocaval confluence : a strategy to achieve R0 liver-sparing resection

enthalten in: Langenbeck's archives of surgery | 2022

von Urbani, L. | Roffi, N. | Signori, S. | +12

18

The management of colorectal liver metastases amenable of surgical resection : How to shape treatment strategies according to clinical, radiological, pathological and molecular features

enthalten in: Cancer treatment reviews | 2022

von Germani, M. | Borelli, B. | Boraschi, P. | +8

19

Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Antoniotti, C. | Marmorino, F. | Boccaccino, A. | +19

20

Homologous Recombination Deficiency Alterations in Colorectal Cancer : Clinical, Molecular, and Prognostic Implications

enthalten in: Journal of the National Cancer Institute | 2022

von Moretto, R. | Elliott, A. | Zhang, J. | +25

CommentIn: J Natl Cancer Inst. 2022 Feb 7;114(2):176-178. - PMID 34469539